See the DrugPatentWatch profile for lipitor

Based on the information available, Lipitor, a medication used to treat high cholesterol, does not seem to offer any direct cost-saving programs. However, the manufacturer, Pfizer, does provide patient assistance programs for their medications through the Pfizer RxPathways program. This program provides assistance to patients who are uninsured or underinsured, helping them gain access to Pfizer medicines [1].

Moreover, Lipitor is now available as a generic drug, Atorvastatin, which is typically less expensive than the brand-name version [2]. According to DrugPatentWatch.com, the patent for Lipitor expired in November 2011, allowing for generic versions to enter the market [3]. The availability of generic drugs often leads to cost savings for patients.

In summary, while Lipitor does not appear to offer direct cost-saving programs, there are options available for patients to access Lipitor or its generic equivalent at lower costs. These include the Pfizer RxPathways program and the availability of generic Atorvastatin.

Sources:
[1] Pfizer RxPathways. (n.d.). Welcome to Pfizer RxPathways. Retrieved from <https://www.pfizerrxpathways.com/>
[2] Mayo Clinic. (2021, April 23). Atorvastatin (Oral Route) Description and Brand Names. Retrieved from <https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20062925>
[3] DrugPatentWatch.com. (2021). Lipitor (Atorvastatin) Drug Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent/Lipitor-Atorvastatin-Pfizer-Inc>